Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 26

Research Methodology
For our study on COPD Drugs Market, we have conducted comprehensive secondary research followed by an
extensive primary research. In the process of secondary research, we have scrutinized industry documents,
accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal
knowledge base. In the process of primary research, we have interviewed various industry experts across the
value chain of COPD Drugs Market.
Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the industry
in the last five years, and confirming the findings through primary research. Annual reports of the companies
are scanned to further validate the market size and to estimate the size of various other end-user sectors.
Market sizing and growth in the forecast period (2018-2023) is estimated through product mapping,
application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the
relevant data points/ statistics in the forecast period are validated through relevant and reliable primary
sources.
Report Focus: COPD Drugs Market:
-By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, Others)
-By Region (North America, Europe, APAC, and ROW)
-By Country (U.S, Canada, Germany, France, U.K., Italy, Japan, China, India)
-Pipeline Analysis (PT010, Duaklir, Nemiralisib, Danirixin)
(c) AZOTH Analytics
26